Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
Rhea-AI Summary
Celldex Therapeutics (NASDAQ:CLDX) announced its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9th, 2025, at 3:20 pm ET.
Investors can access a live webcast of the presentation through the "Events & Presentations" page in the "Investors" section of Celldex's website. The presentation recording will remain available for 90 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, CLDX gained 3.85%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm ET. A live webcast of the presentation will be available on the "Events & Presentations” page of the "Investors" section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
When is Celldex (CLDX) presenting at the Morgan Stanley Healthcare Conference 2025?
How can I watch Celldex's (CLDX) Morgan Stanley conference presentation?
How long will Celldex's (CLDX) Morgan Stanley conference presentation be available?
What type of presentation will Celldex (CLDX) give at the Morgan Stanley conference?
